Is determination of angiogenic activity in human tumours clinically useful?: Arbiter:
- 30 April 1998
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (5) , 615-618
- https://doi.org/10.1016/s0959-8049(97)10042-9
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Antiangiogenic drugs as a novel anticancer therapeutic strategy: Which are the more promising agents? What are the clinical developments and indications?Critical Reviews in Oncology/Hematology, 1997
- Angiogenesis in endocrine-related cancersEndocrine-Related Cancer, 1997
- Angiogenesis research up to 1996. A commentary on the state of art and suggestions for future studiesEuropean Journal Of Cancer, 1996
- Clinical significance of the determination of angiogenic factorsEuropean Journal Of Cancer, 1996
- Role of integrins in angiogenesisEuropean Journal Of Cancer, 1996
- Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluationEuropean Journal Of Cancer, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- 67‐kDa laminin‐receptor expression adds prognostic information to intra‐tumoral microvessel density in node‐negative breast cancerInternational Journal of Cancer, 1995
- Enhancement of Tumor Growth and Vascular Density by Transfection of Vascular Endothelial Cell Growth Factor Into MCF-7 Human Breast Carcinoma CellsJNCI Journal of the National Cancer Institute, 1995
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995